DMII · Drugs Made In America Acquisition II Corp.
$10.11
+0.00 (+0.00%)
At close · Aug 5
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$644.01M
Shares
63.70M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.11
Open$10.11
Day$10.11–10.11
52W$9.86–10.20
Avg vol 30d101K
Short int47K · 0.1% float · 1.6d
Short vol27%
DataDec 2025–Aug 2026
Filing10-Q · May 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+0%
above
RSI (14)
59
neutral
MACD trend
Positive
52-week position
74%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+1%
trailing
YTD return
+2%
this year
Relative strength
−10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
9 of 68 funds reported for Jun 30 · net -194.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.07% of float · ▼ -20.9% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
68 holders — 13F breadth
Squeeze score
37
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
2%
annualized · 1-yr
Max drawdown
−1%
past year
ATR
0.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+0%
Bullish
RSI (14)
59
Neutral
MACD trend
Positive
Bullish
52-week position
74%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
9 of 68 funds reported for Jun 30 · net -194.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.07% of float · ▼ -20.9% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
68 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $10
Now $10 · 74%
52-wk high $10
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DMII
this stock
Drugs Made In America Acquisition II Corp.
|
$644.01M | +2.1% | — | — | 0.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | +0.0% | — | 100.2 | — |
|
NIMU
Non Invasive Monitoring Systems Inc /Fl/
|
$1.63B | +2943.5% | -73.9% | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$887.30M | — | — | — | 1.8% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$599.67M | +2.3% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DMII | -0.1% | +0.1% | +1.2% | +0.0% | +2.1% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -5.6% | -3.2% | -10.1% | -3.1% | -10.8% |
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
8 filings
8 filers